RecruitingPhase 1ketamine

Ketamine Assisted Psychotherapy for Opioid Use Disorder

Sponsored by University of Utah

NCT ID
NCT04892251
Target Enrollment
60 participants
Start Date
2021-05-20
Est. Completion
2024-05-30

About This Study

This pilot clinical trial aims to assess the preliminary efficacy of ketamine as an adjunct for a mindfulness-based intervention for opioid use disorder.

Conditions Studied

Opioid-use Disorder

Interventions

  • MORE+KAP
  • MORE

Eligibility

Age:18 Years - N/A
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

1. Diagnosis of Opioid Use Disorder
2. Receiving OUD treatment with a buprenorphine formulation

Exclusion Criteria:

1. Previous experience with a mindfulness-based intervention program
2. Pregnancy
3. Any serious medical, mental, or cognitive issue that prevents successful participation in a mindfulness-based group treatment program
4. Prior use of ketamine other than as prescribed by a physician
5. Any of the following medical conditions

Blood Vessel Disease Heart Valve Disease Heart Failure Class 2 or Above Heart Disease Pregnancy/Breastfeeding Arteriovenous Malformation History of Intracranial Bleeding or Stroke History of Seizures Hypoxia defined by current need for supplemental oxygen Liver Disease History of allergic reaction to Ketamine Dementia (moderate-severe) History of Psychotic Disorder, Bipolar Disorder, or Personality Disorder Dissociative Identity Disorder

Study Locations (1)

Center on Mindfulness and Integrative Health Intervention Development
Salt Lake City, Utah, United States

Interested in this trial?

Contact the study team to learn more about eligibility and enrollment.

Research Coordinator
CONTACT
801-581-3826eric.garland@socwk.utah.edu
View on ClinicalTrials.gov
Data Source
ClinicalTrials.gov

Last updated from source

Ketamine Assisted Psychotherapy for Opioid Use Disorder | Huxley